RBI
JANX icon

Raiffeisen Bank International’s Janux Therapeutics JANX Stock Holding History

Raiffeisen Bank International’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$920K Buy
60,000
+5,000
+9% +$72.4K 0.01% 421
2026
Q1 		$717K Buy
55,000
+9,000
+20% +$123K 0.01% 423
2025
Q4 		$636K Buy
46,000
+22,000
+92% +$517K 0.01% 411
2025
Q3 		$569K Buy
+24,000
New +$584K 0.01% 409

Other funds holding JANX

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
S
SimplyRich Carlsbad, California $427M AUM 43.67% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Raiffeisen Bank International's JANX Position: Q2 2026 in Review

Raiffeisen Bank International increased its Janux Therapeutics (JANX) stake by 9.1% in Q2 2026, buying an estimated $72.4K and bringing the position to 60,000 shares worth $920K. The position accounts for 0.01% of the portfolio, ranked #421.

Raiffeisen Bank International first reported a position in JANX in Q3 2025 and has held it in 4 quarters since. 32 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Raiffeisen Bank International held 60,000 shares of Janux Therapeutics worth $920K as of Q2 2026.
  • Raiffeisen Bank International bought 5,000 Janux Therapeutics shares in Q2 2026, an estimated $72.4K.
  • Janux Therapeutics made up 0.01% of Raiffeisen Bank International's portfolio in Q2 2026, its #421 holding.
  • Raiffeisen Bank International first reported a position in Janux Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 32 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.